logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mehmet Asım Bilen

Emory University School of Medicine
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer

吸烟、肿瘤遗传学与转移性前列腺癌患者预后的关联

Prostate Cancer and Prostatic Diseases
IF5.8
2026-09-050
PRE
Christopher Choi; Matthew Labriola; Nicholas Henderson; Alec Chu; Clara Hwang; Pedro C. Barata; Frank Cameron Cackowski; Amanda Broderick; Rana R. McKay; Mehmet Asim Bilen; Deepak Kilari; Laura S. Graham; Abhishek Tripathi; Rohan Garje; Vadim S. Koshkin; Tanya B. Dorff; Michael Thomas Schweizer; Zachery R. Reichert; Alexandra O. Sokolova; Catherine H. Marshall; Andrew J. Armstrong
A Stromal–Immune computational pathology Signature for prognosis and immune checkpoint inhibitor Response in localized, locally advanced and metastatic urothelial carcinoma: A Multicenter retrospective Study

基质–免疫计算病理学标志物在局部、局部晚期和转移性尿路上皮癌中的预后预测及免疫检查点抑制剂应答评价：一项多中心回顾性研究

European Journal of Cancer
IF7.1
2026-08-070
OA
Bolin Song; Himanshu Maurya; Tianyi Xia; Naoto Tokuyama; Kamal Hammouda; Xiangxue Wang; Ibrahim Mohammad; Tilak Pathak; Xiuming Zhang; Viraj A. Master; Mehmet Asim Bilen; Shilpa Gupta; Cheng Lu; Hexiang Wang; Anant Madabhushi
TLSB-25 SINGLE-CELL CHARACTERIZATION OF RENAL CELL CARCINOMA BRAIN METASTASIS

TLSB-25 肾细胞癌脑转移的单细胞表征

Neuro-Oncology Advances
IF4.1
2026-08-070
OA
Mostafa I H Ali; Zeynep Feyza Akpinar; Jose A Ovando-Ricardez; Anna K Casasent; Truong Nguyen Anh Lam; Jerome Lin; Narmina Khanmammadova; Patrick K Reville; David J H Shih; Adeboye O Osunkoya; Lisa M Norberg; Tuan M Tran; Jianzhuo Li; Anh G Hoang; Sahin Hanalioglu; Mehmet Asim Bilen; Frederick Lang; Jason T Huse; Nicholas Navin; Merve Hasanov; Eric Jonasch; Elshad Hasanov
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer

阿帕卢他胺与恩扎卢他胺在转移性去势敏感前列腺癌中前列腺特异性抗原反应的实世界比较有效性

Therapeutic Advances in Medical Oncology
IF4.2
2026-05-210
PRE
Mehmet A. Bilen; Benjamin H. Lowentritt; Sabree Burbage; Charmi Patel; Carmine Rossi; Frederic Kinkead; Gordon Wong; Dominic Pilon; Neal D. Shore
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177–PSMA-617

炎症生物标志物在用177Lu–PSMA-617治疗的患者中具有预后作用

Cancer
IF5.1
2026-04-160
PRE
Margo B. Gerke BA; Angelo Marra MPH; Yuan Liu PhD; Akshay Bedmutha MD; Jacqueline T. Brown MD; Bassel Nazha MD; Jacob E. Berchuck MD; Ravi Bharat Parikh MD; Shahid Ahmed MD; Jordan Alana Ciuro MD; Caitlin Hartman FNP; Greta Russler McClintock FNP; Sarah Caulfield PharmD; Omer Kucuk MD; Bradley Curtis Carthon MD, PhD; David M. Schuster MD; Saima Muzahir MD; Mehmet Asim Bilen MD
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Davey, Paris; Vo, BaoHan; Bilen, Mehmet; Liu, Yuan; Davarpanahfakhr, Amir; Nazha, Bassel; Brown, Jacqueline; Osunkoya, Adeboye; Williams, Sierra; Session, Wilena; Hartman, Caitlin; Russler, Greta; Caulfield, Sarah; Joshi, Shreyas; Narayan, Vikram; Ogan, Kenneth; Kucuk, Omer; Carthon, Bradley; Boyanton, Adriana; Master, Viraj; Kissick, Haydn
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617

PSMA阳性转移性去势抵抗性前列腺癌患者接受177Lu-PSMA-617治疗后的基因组改变及关联结局

ONCOLOGIST
IF4.2
2025-11-010
PRE
Panian, Justine; Henderson, Nicholas C.; Herchenhorn, Daniel; Barata, Pedro C.; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S.; Jindal, Tanya; Nauseef, Jones T.; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T.; Raychaudhuri, Ruben; Reichert, Zachery R.; Dorff, Tanya; Armstrong, Andrew J.; Wang, John; Alva, Ajjai; Mckay, Rana R.
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

FGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析

ONCOLOGIST
IF4.2
2025-11-010
PRE
Jiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析

CANCER MEDICINE
IF3.1
2025-10-020
OAAI
Nizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
A Phase 1, multiple-dose study to evaluate the safety and tolerability of first-in-class XmAb819 (ENPP3 x CD3) in subjects with relapsed or refractory clear cell renal cell carcinoma (ccRCC) (NCT05433)

一项I期、多次给药研究，旨在评估首创新药XmAb819 (ENPP3 x CD3)在复发或难治性透明细胞肾细胞癌（ccRCC）受试者中的安全性与耐受性（NCT05433）。

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Bohac, Chet; Pal, Sumanta; Sweis, Randy; Kotecha, Ritesh; Runcie, Karie; Bilen, Mehmet; Braun, David; Tykodi, Scott; Hoimes, Christopher; Suri, Vithika; Kanodia, Jitendra; Salama, Engie; Woo, Jacky; Li, Lingling; Yang, Yuanquan; Franklin, Robert; Maly, Joseph; Grigg, Claud; Gulati, Shuchi; Vanderweele, David J.; Garmezy, Benjamin
CD163+Tumor-Associated macrophages and clinical outcomes to First-Line nivolumab therapy in patients with metastatic clear cel renal cell carcinoma: insights from the HCRN GU16-260 trial

CD163+肿瘤相关巨噬细胞与转移性透明细胞肾细胞癌患者接受一线纳武利尤单抗治疗的临床结局：来自HCRN GU16-260试验的见解

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Simsek, Berkay; Paul, Morgan A.; Xie, Wanling; El Ahmar, Nourhan; Matar, Sayed; Laimon, Yasmin Nabil; RobertiDe Oliveira, Gabriel; Mohanna, Razan; Delcea, Andrew; Choueri, Toni; Braun, David; Sun, Maxine; Haas, Naomi B.; Hammers, Hans J.; Bilen, Mehmet; Stein, Mark N.; Sosman, Jeffrey A.; Freeman, Gordon J.; Wu, Catherine; Mcdermott, David; Atkins, Michael B.; Signoretti, Sabina
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David

研究方向

暂未获取到该数据
V
Viraj A. Master
H 指数:61论文数:949被引数:1.4万
P
Pedro C. Barata
H 指数:33论文数:596被引数:4,656
R
Rana R. McKay
H 指数:57论文数:1,239被引数:1.5万
P
Petros Grivas
H 指数:61论文数:916被引数:2.4万
V
Vadim S. Koshkin
H 指数:29论文数:280被引数:5,246
B
Bradley Curtis Carthon
H 指数:27论文数:251被引数:3,362
C
Christopher Hoimes
H 指数:41论文数:361被引数:7,895
Y
Yousef Zakharia
H 指数:39论文数:662被引数:7,518
H
Haydn Kissick
H 指数:39论文数:242被引数:1.0万
D
Dylan J. Martini
H 指数:24论文数:101被引数:3,212